UNSPSC 85672801: Revision of nonautologous tissue substitute in upper bursa and ligament, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in upper bursa and ligament, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0MWXXKZ

UNSPSC 85672801 Revision of nonautologous tissue substitute in upper bursa and ligament, external approach is a Commodity code that shows minimal alignment between its nominal scope and recent state and local procurement activity tagged under it. The code nominally describes a specific surgical procedure involving tissue-substitute revision, but the recent solicitations tagged to this code include independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, temporary health professional staffing, surgical procedure carve-out benefit programs, and emergency medical services for youth in custody — none of which involve tissue-substitute revision or align with the code's stated orthopedic surgical scope. The mismatch suggests either miscoding by the issuing bodies or a data quality issue in how the opportunities were tagged to this commodity.

The recent opportunities show activity across multiple states and jurisdiction types: the City of Phoenix Retirement Office (Arizona), City of Long Beach (California), Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and County of Santa Clara Health System (California). Representative solicitations include the Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026, $750,000 over five years), Washington State Ferries occupational medical surveillance (RFP20260825, due October 9, 2026), and Long Beach's surgery benefit program RFP (HR26753, due October 7, 2026). Given the disconnect between the code's stated procedure and the actual work being solicited, this code does not represent a viable procurement pursuit vehicle for firms in orthopedic or tissue-substitute markets.